Studies have shown that the incidence of elevated CA19-9 and CEA in patients with hepatic sarcomatoid carcinoma is significantly higher than that in HCC patients, while the incidence of elevated AFP is much lower than that in HCC,[1] which is helpful for the differential diagnosis of HSC and HCC. This evidence concerns the gene CEACAM5 and hepatocellular carcinoma.